New Treatment for Rheumatoid Arthritis

On Behalf of | Nov 13, 2012 | Uncategorized

FDA Regulators in November approved Pfizer’s Xeljanz treatment for rheumatoid arthritis, which is now poised to compete with Abbott Laboratories’ top-selling Humira. Pfizer’s pill is for patients with moderate to severe rheumatoid arthritis who did not benefit from or were unable to tolerate the standard oral treatment, methotrexate. Xeljanz can be used by itself or in combination with methotrexate and certain other treatments.

The F.D.A. approved a 5-milligram dose of Xeljanz, given twice a day. The agency said further safety data was needed to assess a 10-milligram, twice-daily dose, that Pfizer had also put before regulators.


William Wombacher, your Central Illinois Certified Elder Law Attorney (CELA) and Social Security Disability Specialist. I’ll help you!
Serving Peoria, East Peoria, Peoria Heights, Pekin, Dunlap, Chillicothe, Morton, Washington, Metamora, Canton, Galesburg, Bloomington, Normal and surrounding cites and counties of Peoria, Tazewell, Woodford, Fulton and  Knox Counties in Central Illinois.


RSS Feed

I Make Home &
Hospital Visits

Schedule A
Free Consult

Let Me Help

The Law Office of William C. Wombacher

Local: 309-674-8125
Fax: 309-674-8149

Commerce Bank Building
416 Main Street Suite 700
Peoria, IL 61602
NELF | National Elder Law Foundation
CAP | Council of Advanced Practitioners | NAELA | National Academy of Elder Law Attorneys, Inc.
Illinois State Bar Association